Vortioxetine hydrobromide Catalog No.:M10128-10 Selective small molecule compounds increase

Selective small molecule compounds increase BMP-2 responsiveness by inhibiting Smurf1-mediated Smad1/5 degradation

WZ-3146 was identified by screening an irreversible kinase inhibitor library specifically against EGFR T790M

Dual role of isocitratelyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis

Chemical Name: 5-chloro-6-(2

6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)diazenyl)-2

Vortioxetine hydrobromide Catalog No.:M10128-10 Selective small molecule compounds increaseVortioxetine, also known as Lu AA21004, is an atypical antidepressant, and was approved in 2013 by the U. S. FDA for the treatment of major depressive disorder (MDD) in adults. Vortioxetine is a so called "serotonin modulator and stimulator." It has been shown to possess the following pharmacological actions: Serotonin transporter (SERT) blocker (i. e. serotonin reuptake inhibitor (SRI)) Ki (binding affinity) = 1. 6 nM, IC50 = 5. 4 nM; Norepinephrine